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ABSTRACT
Background and Aims The ageing US population is providing an unprecedented population of older adults who use rec-
reational drugs. We aimed to estimate the trends in the prevalence of past-year use of cannabis, describe the patterns and
attitudes and determine correlates of cannabis use by adults age 50 years and older. Design Secondary analysis of the
National Survey on Drug Use and Health survey from 2006 to 2013, a cross-sectional survey given to a nationally repre-
sentative probability sample of populations living in US households. Setting USA. Participants A total of 47140 sur-
vey respondents aged ≥ 50 years. Measures Estimates and trends of past-year use of cannabis. Findings The
prevalence of past-year cannabis use among adults aged ≥ 50 increased significantly from 2006/07 to 2012/13, with a
57.8% relative increase for adults aged 50–64 (linear trend P < 0.001) and a 250% relative increase for those aged
≥ 65 (linear trend P = 0.002). When combining data from 2006 to 2013, 6.9% of older cannabis users met criteria for
cannabis abuse or dependence, and the majority of the sample reported perceiving no risk or slight risk associated with
monthly cannabis use (85.3%) or weekly use (79%). Past-year users were more likely to be younger, male, non-
Hispanic, not have multiple chronic conditions and use tobacco, alcohol or other drugs compared with non-past-year can-
nabis users. Conclusions The prevalence of cannabis use has increased significantly in recent years among US adults
aged ≥ 50 years.
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INTRODUCTION
The United States is experiencing sweeping changes in at-
titudes towards cannabis (‘marijuana’) use and associated
policy. Recreational cannabis use was legalized in 2012
in Colorado and Washington states [1,2], with additional
states decriminalizing its use and/or allowing the prescrib-
ing of medical cannabis [3]. This is occurring in the setting
of a rapidly aging population, with the large Baby Boomer
generation (born between 1946 and 1964) reaching
65 years of age in 2011 [4]. The Baby Boomer generation
has higher reported rates of substance use compared to
any generation preceding it, and stark differences in atti-
tudes towards recreational and illicit drug use [5–7]. How-
ever, there is limited research that addresses the
epidemiology and health status of older adults who use
drugs. We also understand little about how drug use im-
pacts aging or how aging influences substance use. The
lack of knowledge in this area constrains the care for a
changing demographic of older adults with higher rates
of substance use.
Cannabis is not only one of the most commonly used
drugs in the United States [8], western and central
Europe and Oceania [9]; it is also the most prevalent drug
after alcohol and tobacco used by adults aged 50 and older
in the United States and the United Kingdom [5,10]. A
recent study using the National Epidemiologic Survey on
Alcohol and Related Conditions showed that the preva-
lence of past-year cannabis use more than doubled from
2001–02 to 2012–13 [11], with large increases among
those aged 45–64 years. Another recent study using
age–period–cohort analysis found that recent increases in
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past-year cannabis use are not unique to younger genera-
tions [12].
However, only a handful of studies have examined
cannabis use among older adults. Studies show that the
majority of older adults who use cannabis started their
use as adolescents or as young adults [13]. Prevalence of
past-month cannabis use among older adults with depres-
sion who sought mental health treatment was found to be
12% for men and 4% for women [14]. A cross-sectional
study of the 1999–2001 National Household Surveys on
Drug Abuse showed that lower education level was corre-
lated with past-year cannabis use by adults aged 50 and
older [15] and analysis of the 2008 National Survey on
Drug use and Health (NSDUH) showed that among
middle-aged and older adults, cannabis users were more
likely to be younger, black and more likely to smoke ciga-
rettes and/or use other substances [16]. Another recent
study using the 2012–13 National Epidemiologic Survey
on Alcohol and Related Conditions (NESARC-III) found
that among adults aged 50 and older, 3.9% reported
past-year cannabis use and 21.7% reported being former
users, and both past-year and former users had high risk
for mental disorders [17]. However, more studies examin-
ing current trends over time and correlations of cannabis
use by older adults are lacking.
Amid recent changes in attitudes towards cannabis and
increasing support for legalization [18–20], coupled with
the continued aging of the Baby Boomer generation and
the potential use of cannabis to cope with aging and
chronic disease side effects [21,22], cannabis use by older
adults may continue to increase. A large international
survey on the medicinal use of cannabis conducted by
the International Association for Cannabinoid Medicine
in 31 countries found that 30.5% of the 953 participants
surveyed were over the age of 50 [23]. The survey also
found that the top five indications for cannabis use in-
cluded chronic pain, anxiety, loss of appetite or weight loss,
depression or sleeping disorder, all common conditions in
older age. While an abundance of research has focused
upon cannabis as a risk factor for neurocognitive abnor-
malities in the developing brain of adolescents [24,25],
there may be distinctive risks of cannabis use by older
adults such as cognitive impairment or cardiovascular risk
[6], and these are not well understood. Further studies are
needed to determine changes in the characteristics of older
adults who use cannabis, andwhat potential risks and ben-
efits it may pose.
In summary, while we recognize that cannabis use may
be increasing among older adults, recent trends in preva-
lence of cannabis use and patterns, attitudes and correlates
of its use by middle-aged and older adults are lacking. With
the aim of filling key gaps in the current literature, the pres-
ent study aims to: [1] estimate the prevalence of past-year
cannabis use by older adults from 2006 to 2013; [2] report
on the trends in past-year cannabis use byolder adults from
2006 to 2013; [3] describe patterns and attitudes regard-
ing cannabis use among past-year older users during the
study period; and [4] determine correlates of past-year can-
nabis use among older adults. To address these questions,
the current study used cross-sectional data from eight
years (2006–13) of a nationally representative sample of
non-institutionalized individuals in the United States.
METHODS
Data source and study population
Data were obtained from the last eight cohorts (2006–13)
of NSDUH, an ongoing cross-sectional survey of non-
institutionalized individuals in the 50 US states and the
District of Columbia [26], with different participants sam-
pled each year and therefore independent of each other.
NSDUH is a nationally representative probability sample
of populations living in households obtained through four
stages. Census tracts were first selected within each state,
then segments in each tract, then dwelling, and then re-
spondents were selected for the final sample each year.
Surveys were administered via computer-assisted
interviewing (CAI) conducted by an interviewer and audio
computer-assisted self-interviewing (ACASI). Sampling
weights were provided by NSDUH to address unit- and
individual-level non-response. Weights were adjusted to
ensure that estimates were consistent with estimates pro-
vided by the US Census Bureau. Further information on
sampling and survey techniques can be found elsewhere
[26]. The weighted interview response rates for 2006–13
NSDUH ranged from 71.7 to 75.7%.
Measures
Participants were asked whether they had used ‘mari-
juana’ within the last 12 months. They were also asked
whether they had used tobacco, alcohol or illicit drugs
other than ‘marijuana’. Participants were asked about
their perception of risk of using ‘marijuana’ once a month
and answer options were ‘no risk’, ‘slight risk’, ‘moderate
risk’ and ‘great risk’. The sample was also asked about per-
ception of risk of using ‘marijuana’ once or twice a week
and they were provided with the same answer options.
Those who reported cannabis use were also asked some
follow-up questions about use. Participants answered a se-
ries of questions that determined whether criteria would
meet Diagnostic and Statistical Manual of Mental Disor-
ders, 4th edition (DSM-IV) abuse or dependence for canna-
bis. While not a diagnostic interview, this provided a proxy
diagnosis. Participants were also asked their age of canna-
bis initiation and frequency of use during the last
12 months. Those reporting use were also asked about
their method of obtaining ‘marijuana’ the last time they
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used it and answer options were ‘bought’, ‘traded for it’,
‘received it for free/shared’, ‘grew it’ and ‘unspecified’. Sim-
ilarly, those reporting use were asked about the source of
their most recent ‘marijuana’ purchase and answer op-
tions were ‘bought it from a friend’, ‘relative/family’, ‘some-
one they just met or did not know’ and ‘unspecified’.
We examined subject age (predefined as ageds 50–64
and ≥ 65), gender, race (i.e. white non-Hispanic, black
non-Hispanic, Hispanic, other race), educational attain-
ment (i.e.< high school, high school, some college, college
or more), annual total income (i.e. < $20000; $20000–
49999; $50000–74999; $75000+) and marital status
(i.e. married, widowed, divorced or separated or never
married).
Participants were asked if they were ever told by a doc-
tor or other medical professional that they have had any of
the following chronic diseases: diabetes, heart disease,
stroke, sleep apnea or cirrhosis. We recoded the responses
into a binary variable indicating multiple chronic condi-
tions (‘yes’ indicating that the participant reported two or
more of the listed chronic diseases and ‘no’ signifying hav-
ing fewer than two of the chronic diseases). Participants
were also asked whether they had experienced depression
or anxiety within the last year. They were also asked
whether had received mental health treatment within
the last year.
Statistical analyses
To achieve the aims of this study, we focused on individuals
aged ≥ 50, who represented approximately 22–25% of the
full sample eachyear. As self-reported cannabis use was rel-
atively rare, we aggregated years into pairs to increase
power to detect trends over time. Specifically, similar to pre-
vious analyses [11,27], we collapsed years into 2006–07,
2008–09, 2010–11 and 2012–13.
We first examined descriptive statistics to estimate the
weighted prevalence of self-reported past-year use of can-
nabis across cohorts, as well as the prevalence of past-year
use of cannabis separately for each category of each covar-
iate. We computed the absolute change over time by
subtracting prevalence of cannabis use in 2012/13 from
that in 2006/07. We also computed the relative change
over time by dividing the prevalence of cannabis use in
2012/13 by that in 2006/07. We then estimated whether
there was a linear association between cannabis use and
time within each of the covariate categories; statistical sig-
nificance was assessed at the two-sided α < 0.05 level. We
further estimated weighted prevalences of the patterns and
attitudes regarding cannabis use among past-year self-
reported cannabis users aged 50 and older, aggregating
the sample across all years from 2006 to 2013. In particu-
lar, we estimated overall weighted prevalence of DSM-IV
cannabis abuse or dependence, age of first use, frequency
andmethod of obtaining cannabis, as well as perceived risk
associated with cannabis use.
We then estimated odds of cannabis use over time and
by socio-demographic, substance use, and health covari-
ates in the full sample using logistic regression. Separate
bivariable models were used to determine associations be-
tween each covariate and cannabis use, which produced
unadjusted odds ratios (ORs), and a multivariable model
was computed to examine the association of all covariates
with all else being equal. This produced an adjusted OR
(aOR) for each level of each covariate. We conducted sensi-
tivity analyses testing two- and three-way interactions be-
tween age, gender and time to assess, for example, whether
the adjusted odds of cannabis use over time differed be-
tween older and younger females. Analyses were weighted
to account for the complex survey design. As our analyses
used data from eight NSDUH years, we divided the survey
weights by 8 to obtain nationally representative estimates.
Data were analyzed using Stata SE version 13 (StataCorp,
College Station, TX, USA; 2009), which used the Taylor se-
ries estimation methods to provide accurate standard er-
rors [28]. This secondary data analysis of publically
available datawas exempt for review by the New York Uni-
versity Langone Medical Center Institutional Review
Board.
RESULTS
Sample characteristics across cohorts are presented in
Table 1. The prevalence of past-year cannabis use among
adults aged 50 and older increased significantly from
2006/07 to 2012/13 (Table 2). The prevalence in
2006/07 increased significantly to 2012/13 from 2.8 to
4.8% (P < 0.001), and this was a 71.4% relative increase.
Older adults aged ≥ 65 had a significantly lower preva-
lence of cannabis use compared to adults aged 50–64
(i.e. 1.4 versus 7.1% in 2012/13); however, ages 65+
had a larger relative increase (250%) than adults aged
50–64 (57.8%).
Prevalence of past-year cannabis usewas higher among
men than women throughout all years, and in 2012/13
the prevalence of past-year cannabis use among men was
twice as high as the prevalence among women over the
age of 50 (6.8 versus 3.0%). The prevalence of self-reported
past-year cannabis use was increased significantly by 76%
among non-Hispanic white participants from 2006/07 to
2012/13 (P < 0.001). Past-year cannabis use increased
significantly from 2006/07 to 2012/13 among individuals
across all levels of education (Ps< 0.05), with incomes be-
low $50000 (Ps < 0.01) and those who were married
(P < 0.001), divorced or separated (P < 0.05).
The 2012/13 prevalence of past-year cannabis use
among reported past-year illicit (other than ‘marijuana’)
drug users was 34.8%, a relative increase of 16.8% since
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2006/07; however, this was not a significant trend
(P = 0.257). The prevalence in 2012/13 of past-year use
of cannabis among those who reported past-year alcohol
use was 6.7%, a significant increase from 2006/07
(P < 0.001). Past-year cannabis use also increased signifi-
cantly among past-year tobacco smokers, with a











Prevalence of cannabis use 2.8 3.3 4.1 4.8 3.8
Age group (years, %)
50–64 59.4 (6904) 59.5 (6778) 59.6 (7742) 58.7 (7859) 59.3 (29 283)
65+ 40.6 (4277) 40.5 (4113) 40.4 (4630) 41.3 (4837) 40.7 (17 857)
Gender
Male 46.0 (5044) 46.3 (4912) 46.5 (5585) 46.8 (5698) 46.4 (21 239)
Female 54.0 (6137) 53.7 (5979) 53.5 (6787) 53.2 (6998) 53.6 (25 901)
Race/ethnicity
Non-Hispanic White 77.5 (8813) 76.7 (8297) 76.1 (9369) 74.6 (9400) 76.2 (35 879)
Non-Hispanic Black 9.7 (984) 9.8 (1045) 9.8 (1264) 10.3 (1364) 9.9 (4657)
Hispanic 7.9 (781) 8.2 (909) 8.7 (989) 9.3 (1122) 8.6 (3801)
Other 4.9 (603) 5.3 (640) 5.5 (750) 5.8 (810) 5.4 (2803)
Education
<High school 18.3 (2031) 16.5 (1917) 15.1 (1956) 14.4 (1981) 16.0 (7885)
High school 32.0 (3760) 33.0 (3622) 32.3 (4094) 31.6 (4193) 32.2 (15 669)
Some college 22.0 (2482) 22.1 (2506) 23.0 (2934) 24.0 (3087) 22.8 (11 009)
College or more 27.7 (2908) 28.4 (2846) 29.6 (3388) 30.0 (3435) 29.0 (12 577)
Income
<$20 000 40.4 (4574) 38.4 (4436) 39.1 (4997) 37.2 (5037) 38.7 (19 044)
$20–49999 35.8 (4190) 37.2 (4078) 35.0 (4497) 36.1 (4672) 36.0 (17 437)
$50000–74 999 12.4 (1287) 12.5 (1300) 12.5 (1468) 12.5 (1453) 12.5 (5508)
≥ $75 000 11.4 (1130) 11.8 (1077) 13.4 (1410) 14.2 (1534) 12.8 (5151)
Marital status
Married 63.6 (7032) 64.0 (6687) 62.2 (7520) 61.8 (7517) 62.9 (28 756)
Widowed 14.8 (1622) 13.5 (1465) 13.5 (1646) 13.0 (1652) 13.7 (6385)
Divorced or separated 15.6 (1811) 15.8 (1928) 17.9 (2307) 18.5 (2534) 17.0 (8580)
Never married 6.0 (716) 6.7 (811) 6.4 (899) 6.6 (993) 6.4 (3419)
Any tobacco use
Past year no use 76.0 (8387) 76.3 (8209) 77.3 (9322) 77.6 (9569) 76.8 (35 487)
Past year use 24.0 (2794) 23.7 (2683) 22.7 (3050) 22.4 (3127) 23.2 (11 653)
Alcohol use
No past-year use 40.5 (4495) 38.6 (4300) 38.7 (4841) 37.5 (4847) 38.8 (18 483)
Past-year use 59.5 (6686) 61.4 (6591) 61.3 (7531) 62.5 (7849) 61.2 (28 657)
Illicit drug other than marijuana
No past-year use 97.4 (10 903) 97.2 (10 560) 97.4 (12 029) 96.7 (12 277) 97.2 (45 769)
Past-year use 2.6 (278) 2.8 (331) 2.6 (343) 3.3 (419) 2.8 (1371)
Chronic diseasea
Multiple chronic conditions (≥ 2 chronic disease)
No 83.5 (9310) 81.5 (8852) 81.2 (10 002) 81.1 (10 321) 81.8 (38 485)
Yes 16.5 (1871) 18.5 (1998) 18.8 (2313) 18.9 (2375) 18.2 (8557)
Mental health
Depression in the past year
No 93.0 (10 361) 92.8 (10 027) 93.2 (11 417) 92.4 (11 660) 92.8 (43 465)
Yes 7.0 (820) 7.2 (815) 6.8 (896) 7.6 (1036) 7.2 (3567)
Anxiety in past year
No 96.1 (10 727) 95.4 (10 349) 95.7 (11 748) 95.0 (11 979) 95.5 (44 803)
Yes 3.9 (454) 4.6 (498) 4.3 (566) 5.0 (717) 4.5 (2235)
Received mental health treatment in past year
No 87.3 (9645) 86.7 (9381) 86.9 (10 622) 85.2 (10 679) 86.5 (40 345)
Yes 12.7 (1495) 13.3 (1473) 13.1 (1704) 14.8 (1947) 13.5 (6619)
aChronic diseases include diabetes, heart disease, stroke, sleep apnea and cirrhosis.
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prevalence of 12.3% in 2011/12 (P< 0.001). In addition,
cannabis use increased significantly throughout the entire
study period among those over the age of 50 with two or
more chronic conditions (P = 0.001), depression in the
past year (P = 0.001) and adults who received mental
health treatment (P = 0.002).
Table 2 Prevalence estimates for self-reported past-year cannabis use by socio demographics, chronic disease and substance use
characteristics for adults 50 years and older, United States 2006–13.
2006/2007
(n = 11 181)
2008/2009
















Prevalence of cannabis use 2.8 3.3 4.1 4.8 +2.0 +71.4 <0.001
Age group (years)
50–64 4.5 5.2 6.1 7.1 +2.6 +57.8 <0.001
65+ 0.4 0.6 1.1 1.4 +1.0 +250.0 0.002
Characteristic
Gender
Male 4.4 4.5 5.6 6.8 +2.4 +54.5 <0.001
Female 1.5 2.2 2.8 3.0 +1.5 +100.0 <0.001
Race/ethnicity
Non-Hispanic white 2.9 3.2 4.2 5.1 +2.2 +75.9 <0.001
Non-Hispanic black 3.7 4.8 5.0 5.3 +1.6 +43.2 0.188
Hispanic 1.8 1.9 3.4 2.6 +0.8 +44.4 0.210
Other 1.2 3.6 2.7 3.5 +2.3 +191.7 0.140
Education
<High school 2.5 2.5 5.1 5.1 +2.6 +104.0 0.008
High school 2.4 3.4 3.2 4.6 +2.2 +91.7 0.001
Some college 3.5 3.8 5.4 4.7 +1.2 +34.3 0.016
College or more 3.0 3.2 3.6 5.3 +2.3 +76.7 0.003
Income
<$20 000 2.5 3.0 4.9 5.4 +2.9 +116.0 <0.001
$20–49 999 2.5 3.2 3.4 4.1 +1.6 +64.0 0.002
$50 000–74 999 3.7 3.6 3.9 4.7 +1.0 +27.0 0.360
≥ $75 000 4.1 4.5 4.0 4.8 +0.7 +17.1 0.636
Marital status
Married 1.9 2.5 3.0 4.0 +2.1 +110.5 <0.001
Widowed 1.0 1.1 1.8 1.6 +0.6 +60.0 0.092
Divorced or separated 6.6 6.5 8.1 8.5 +1.9 +28.8 0.032
Never married 7.0 7.3 8.7 8.1 +1.1 +15.7 0.364
Any tobacco use
Past-month use 7.4 9.0 10.6 12.3 +4.9 +66.2 <0.001
Past-year use 7.7 8.9 10.4 12.0 +4.3 +55.8 <0.001
Alcohol use
Past-month use 4.6 5.4 6.2 7.4 +2.8 +60.9 <0.001
Past-year use 4.1 4.9 5.8 6.7 +2.6 +63.4 <0.001
Binge alcohol use in past 30 days 8.0 11.0 11.5 13.4 +5.4 +67.5 0.001
Illicit drug other than marijuana
Past-month used 28.7 32.8 29.9 39.3 +10.6 +39.9 0.196
Past-year use 29.8 30.1 30.5 34.8 +5.0 +16.8 0.257
Chronic diseasesb
Multiple chronic conditions
(≥ 2 chronic disease)
1.7 2.2 3.2 3.6 +1.9 +111.8 0.001
Mental health
Depression in the past year 5.7 4.7 9.3 11.4 +5.7 +100.0 0.001
Anxiety in past year 8.2 4.8 9.5 9.0 +0.8 +9.8 0.247
Received mental health treatment
in past year
5.3 5.6 7.3 9.2 +3.9 +73.6 0.002
aLinear time trend from 2006/07 to 2012/13 estimating odds of past year cannabis use by demographic subgroup. bChronic diseases include diabetes, heart
disease, stroke, sleep apnea and cirrhosis.
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Table 3 presents use characteristics and perceived risk
of cannabis use among the 1919 individuals who re-
ported past-year cannabis use in the sample of aggregated
data from 2006 to 2013. Within this subsample of past-
year cannabis users, 6.9% of those met DSM-IV criteria,
abuse or dependence. Most reported initiating cannabis
use before the age 18 and reported either buying it or re-
ceiving it free. The frequency of reported cannabis use
had two peaks: almost a third (30.8%) reporting using
1–11 days, and almost a quarter (24.2%) reportedly
using on 100–299 days in the past year. The majority
of cannabis users reported perceiving either no risk or
slight risk of using cannabis monthly (85.3%) or once
or twice a week (79.0%).
Adjusted results from the multivariable logistic regres-
sion model suggest that younger (50–64) participants
(versus older; ≥ 65), males (versus females), those
reporting an annual household income < $20000 (ver-
sus incomes > $20000) and those who reported being
divorced or never married (versus married) had higher
odds of reporting past-year cannabis use (Table 4). Past-
year use of tobacco, alcohol and illicit drugs robustly in-
creased the odds for reporting past-year cannabis use.
History of multiple chronic conditions was associated
with lower odds of reporting past-year cannabis use, but
those who received mental health treatment were at
higher odds for reporting cannabis use. The association
between cannabis use and past year anxiety or depression
was no longer statistically significant after adjusting for
other participant characteristics. In sensitivity analyses,
we found no statistically significant interaction between
time and gender or age, indicating no differential change
in the relationship between cannabis use by gender or age
over time. Of note, we found a significant interaction be-
tween gender and age, indicating lower odds of cannabis
use among women aged 65+ compared to women
aged 50–64 (aOR = 0.66, 95% confidence interval
0.45–0.96). There was no substantive change in the
magnitude or direction of the other covariates in the ad-
justed model.
DISCUSSION
The prevalence of cannabis use among older adults is in-
creasing; however, little is known about recent trends
and correlates of use. We found a significant increase in
the prevalence of past-year cannabis use in the United
States among older adults from 2006/07 to 2012/13,
with large relative increases particularly among those
aged 65 and older. There was a significant increase in re-
ported cannabis use among those who also reported use
of tobacco, alcohol or other illicit drugs. However, the
prevalence increased significantly across almost all char-
acteristics except for race/ethnicity, with only non-
Hispanic whites reporting significant increases over time.
Demographic correlates of past-year use of cannabis that
include younger age, male, not married and low income
are similar to past studies [15,16], although our study
also showed a large increase in use by non-Hispanic
whites.
This increase in cannabis use is not unanticipated,
given the high rates of substance use among the Baby
Boomer generation. The trends noted in our study are
probably capturing a major transition in the aging of the
Baby Boomer generation, and highlights how this cohort
of older adults are different in substance use behaviors
compared to the generation before it. Given that the major-
ity of Baby Boomers have still not yet reached the age 65,
Table 3 Patterns and attitudes regarding cannabis use among





















Method of obtaining last used cannabis
Bought 45.7 855
Traded for it 1.7 35
Received free/shared 48.0 934
Grew it 3.2 60
Unspecified 1.4 35
Source of last used cannabis bought
Friend 74.6 791
Relative/family 7.0 77
Someone just met/did not know 13.2 129
Unspecified 5.3 70
Perceived risk of cannabis use once a month
No risk 46.6 880
Slight risk 38.7 713
Moderate risk 10.5 219
Great risk 4.1 96
Perceived risk of cannabis use once or twice a week
No risk 37.3 703
Slight risk 41.7 779
Moderate risk 16.1 312
Great risk 5.0 110
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we will probably continue to see the trends continue into
the next decade. In addition, with shifting attitudes and le-
galization of recreational cannabis and its use for medicinal
purposes, further research is needed to determine whether
these changes in attitudes and/or policies affect prevalence
of use among older adults, particularly in other countries.
With increased availability and use of cannabis by
older adults, the benefits and risks of cannabis need to
be evaluated rigorously. Alcohol use among older adults
has been studied in depth, so we have an adequate un-
derstanding the specific risks [29,30], potential benefits
[31,32], guidelines for quantifying recommended limits
Table 4 Multivariable logistic regression of past-year cannabis use by sociodemographic, substance use, and health characteristics among
aged adults ≥ 50 years in the 2006–13 NSDUH (n = 47140).
Characteristic OR (95% CI) P-value aOR (95% CI) P-value
Year
2006–07 1.00 1.00
2008–09 1.17 (0.95, 1.44) 0.141 1.14 (0.91, 1.42) 0.224
2010–11 1.47 (1.22, 1.78) <0.001 1.53 (1.26, 1.86) <0.001
2012–13 1.72 (1.40, 2.11) <0.001 1.78 (1.43, 2.22) <0.001
Age group (years)
50–64 1.00 1.00
65+ 0.15 (0.11, 0.19) <0.001 0.26 (0.20, 0.34) <0.001
Gender
Male 1.00 1.00
Female 0.44 (0.39, 0.49) <0.001 0.50 (0.44, 0.57) <0.001
Race/ethnicity
Non-Hispanic white 1.00 1.00
Non-Hispanic black 1.23 (1.00, 1.52) 0.047 0.97 (0.76, 1.23) 0.808
Hispanic 0.62 (0.47, 0.83) 0.002 0.59 (0.43, 0.81) 0.002
Other 0.72 (0.51, 1.02) 0.064 0.86 (0.60, 1.23) 0.395
Education
<High school 1.00 1.00
High school 0.99 (0.81, 1.21) 0.902 0.84 (0.65, 1.07) 0.154
Some college 1.28 (1.06, 1.55) 0.013 1.03 (0.83, 1.29) 0.786
College or more 1.11 (0.91, 1.35) 0.318 1.05 (0.80, 1.37) 0.741
Income
<$20000 1.00 1.00
$20 000–49999 0.83 (0.72, 0.95) 0.008 0.73 (0.63, 0.84) <0.001
$50 000–74999 1.00 (0.84, 1.18) 0.998 0.65 (0.53, 0.79) <0.001
≥ $75 000 1.10 (0.91, 1.32) 0.306 0.67 (0.53, 0.83) 0.001
Marital status
Married 1.00 1.00
Widowed 0.48 (0.36, 0.63) <0.001 1.08 (0.81, 1.43) 0.605
Divorced or separated 2.73 (2.36, 3.17) <0.001 1.89 (1.62, 2.22) <0.001
Never married 2.83 (2.32, 3.46) <0.001 1.78 (1.41, 2.24) <0.001
Tobacco use
No past year use 1.00 1.00
Past year use 5.38 (4.70, 6.17) <0.001 2.92 (2.49, 3.41) <0.001
Alcohol use
No past year use 1.00 1.00
Past year use 4.72 (3.86, 5.77) <0.001 3.42 (2.79, 4.19) <0.001
Illicit drug other than marijuana
No past-year use 1.00 1.00
Past-year use 15.01 (12.46, 18.08) <0.001 7.43 (6.07, 9.10) <0.001
Chronic diseasea
Multiple chronic conditions (≥ 2 chronic disease) 0.68 (0.57, 0.80) <0.001 0.83 (0.69, 0.99) 0.040
Mental health
Depression in the past year 2.40 (1.98, 2.91) <0.001 1.30 (0.94, 1.81) 0.109
Anxiety in past year 2.29 (1.88, 2.80) <0.001 1.07 (0.78, 1.45) 0.675
Received mental health treatment in past year 2.22 (1.96, 2.52) <0.001 1.44 (1.15, 1.79) 0.002
aChronic diseases include diabetes, heart disease, stroke, sleep apnea and cirrhosis. OR = odds ratio; aOR = adjusted OR; CI = confidence interval.
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of alcohol for older adults [33] and screening and treat-
ment [6]. However, little to no research has examined
cannabis use among older adults in the same manner.
While studies examining the benefits of cannabis for
medicinal use is emerging, such as for chronic pain
[34], the risks for older adults have not been well
defined.
Aging is characterized by physiological and social
changes that make older adults vulnerable to impaired
function, chronic disease and geriatric conditions such
as falls and cognitive impairment [35]. Therefore, the
physiological effects of cannabis may lead to poor out-
comes in vulnerable older adults who have multiple
chronic conditions. For instance, its effects on increasing
heart rate may increase the risk of cardiovascular dis-
ease, particularly among older adults who may have
pre-existing disease [36]. Smoking cannabis may also
lead to lung illness and infection, and older adults are
more vulnerable to such conditions [36]. Cannabis has
also been tied to cerebrovascular events [37] for which,
again, increasing age is a risk factor. In addition, canna-
bis use has acute effects on cognitive function, and may
have residual long-term effects [23,38]. A recent study
that followed a cohort of adults (aged 18–30) for
25 years found that current use at follow-up was associ-
ated with impaired verbal memory and slower processing
speed, while past cumulative exposure was associated
with impaired verbal memory, but not with other cogni-
tive functioning [39]. It is unclear how the effects of can-
nabis on cardiovascular, cognitive and pulmonary
function may ultimately impact upon the chronic dis-
eases, geriatric conditions and everyday function of older
adults.
This study shows significant increases in cannabis
use throughout the study period by adults with multi-
ple chronic conditions, which has not been described
previously. Therefore, an increasing number of older
adults with chronic diseases appear to be especially
vulnerable to the possible risks of cannabis. In addition,
our study showed that the majority of older adults who
reported cannabis use perceived that cannabis is associ-
ated with either no risk or only a slight risk. One
particular concern is falls among older adults who use
cannabis.
Unintentional falls are a common event for older adults
and a major cause of morbidity andmortality linked with a
decline in functional status and disability [40]. Alcohol use
has been associated with falls among older adults [33], but
no studies have examined the risk of falls among older can-
nabis users. Therefore, as further studies define more
clearly the risks of cannabis for older adults, patients need
to be educated about them.
Furthermore, we also describe an older population that
may be at particularly high risk given their likelihood of
also cigarette smoking, and/or use of alcohol or illicit
drugs, which was found in an earlier study [16]. The
concurrent use of multiple substances may make older
adults further vulnerable to poor physical and mental
health outcomes [6], and may impact upon their care. In
addition, older adults are not as likely to be screened for
substance use [41], often because of perceptions of older
adults as being unlikely to engage in such behaviors [42].
The findings from this study highlight the imperative to
screen older adults for substance use.
This study was subject to limitations. The NSDUH re-
plies on self-report and therefore is subject to recall bias
and social-desirability bias. The latter may be particularly
true for alcohol or drug use where respondents may not re-
port their substance use [43]. Also, recall bias in particular
may be an issue for older adults to recall events from the
distant past (for example, age of initiation of cannabis
use). Secondly, because NSDUH samples the civilian, non-
institutionalized population, it does not include homeless,
active-duty military, incarcerated or institutionalized
adults who may have different drug patterns than those
surveyed. Thirdly, because of changes to the NSDUH survey
throughout the years, we were unable to examine canna-
bis use by metropolitan statistical area for the entire study
period, limiting further examination of cannabis use by
urbanicity. In addition, we were unable to assess the use
of cannabis for medical purposes or as recommended by a
health-care professional, as this was only introduced in
the NSDUH in 2013 [26]. Therefore, we are unable to as-
sess whether the increased use of cannabis by older adults
was due to medicinal use, nor could we assess trends of
cannabis use for medical purposes. Future studies will be
needed to examine trends of cannabis use for medical rea-
sons by older adults. Finally, the survey is cross-sectional,
and different participants were sampled each year of the
study period; therefore, this study cannot establish
causality.
CONCLUSIONS
This study shows that prevalence of self-reported cannabis
use in the past year is increasing among older adults in the
United States. Findings add evidence to dispel the myth
that older adults do not use recreational drugs; we hope
the results encourage providers to screen patients of all
ages for substance use. The changing landscape towards
normalized and legalized cannabis throughout the world
dictates further studies to understand more clearly the vul-
nerabilities, benefits and risks of its use by older adults, sim-
ilar to how we now understand alcohol use among older
adults. In particular, understanding how cannabis use
may affect geriatric conditions and function in older adults
with multiple chronic conditions living in different coun-
tries is an imperative.
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